Vertex Pharmaceuticals (VRTX) RSI Live Chart
Vertex Pharmaceuticals (VRTX) is trading around $553.60. Its daily RSI is 64.44, which is neutral, and its weekly RSI is 62.44 (neutral). The table below shows the live RSI on every timeframe.
Vertex Pharmaceuticals RSI by timeframe
| Timeframe | RSI (14) | Signal |
|---|---|---|
| 30m | 49.61 | Neutral |
| 1h | 56.16 | Neutral |
| 1d | 64.44 | Neutral |
| 1w | 62.44 | Neutral |
| 1mo | 62.15 | Neutral |
Live, updates every few minutes. RSI period 14.
Vertex Pharmaceuticals at a glance
- 1 week
- +6.95%
- 1 month
- +9.69%
- 3 months
- +15.65%
- 1 year
- +31.77%
- 52-week high
- $568.39
- 52-week low
- $404.67
- Market cap
- $140.32B#82 in the S&P 500
- Next earnings
- Mon, Nov 2, 2026
Vertex Pharmaceuticals (VRTX) is an S&P 500 company in the Health Care sector, classified under Biotechnology and headquartered in Boston, Massachusetts. Founded in 1989, it has been in the index since 2013. By market cap it is the 82nd largest company in the S&P 500 and the 13th largest of 60 in Health Care.
Over the past year VRTX is up 31.8%, while the S&P 500 (SPY) is up 10.6%. It trades 2.6% below its 52-week high of $568.39 and 36.8% above its 52-week low of $404.67. Its next earnings report is due Mon, Nov 2, 2026.
What the VRTX RSI tells you
The Relative Strength Index (RSI) measures the speed and size of recent price moves on a scale from 0 to 100. It is one of the most widely used momentum indicators in stock trading.
A reading at or below 30 is considered oversold: selling may be overextended and a bounce more likely. A reading at or above 70 is overbought: buying may be stretched and a pullback more likely. Between 30 and 70 is neutral. Signals are strongest when several timeframes agree, which is why the table above shows Vertex Pharmaceuticals on all of them at once.
RSI is a guide, not a guarantee. A stock can stay oversold or overbought for a long time in a strong trend. Traders usually combine it with divergences, volume and structure, all of which you can check on the live chart.